A thoughtful and defensible valuation is core to any capital raise or acquisition. The Viridian team has extensive experience in and knowledge of the evolving dynamics and the competitive landscape within the cannabis industry. Viridian’s proprietary Cannabis Deal Tracker provides us with current information on valuations from both public and private transactions as well as real-time changes in industry dynamics. Since its inception, our Viridian Cannabis Deal Tracker has sourced and analyzed more than 2,100 capital raises totaling over $24 billion, as well as over 700 M&A transactions, providing to us significant capital markets intelligence around deal terms and structures as well as keeping us apprised of investment and M&A trends across the global cannabis industry.
Past Valuation Assignments
We utilize multiple methodologies that triangulate a valuation defensible to the most sophisticated capital sources. These methodologies include discounted cash flow (DCF) as well as comparable, leveraged buyout (LBO), and precedent transaction analyses.
*Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.